Cartesian Therapeutics (RNAC) Change in Receivables (2016 - 2025)
Historic Change in Receivables for Cartesian Therapeutics (RNAC) over the last 11 years, with Q3 2025 value amounting to $368000.0.
- Cartesian Therapeutics' Change in Receivables rose 10135.24% to $368000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.1 million, marking a year-over-year decrease of 585217.39%. This contributed to the annual value of -$5.0 million for FY2024, which is 58842.98% down from last year.
- Latest data reveals that Cartesian Therapeutics reported Change in Receivables of $368000.0 as of Q3 2025, which was up 10135.24% from -$1.4 million recorded in Q2 2025.
- In the past 5 years, Cartesian Therapeutics' Change in Receivables ranged from a high of $30.0 million in Q2 2024 and a low of -$27.2 million during Q3 2024
- In the last 5 years, Cartesian Therapeutics' Change in Receivables had a median value of -$329000.0 in 2022 and averaged -$342210.5.
- As far as peak fluctuations go, Cartesian Therapeutics' Change in Receivables soared by 1359186.99% in 2022, and later plummeted by 548726.9% in 2024.
- Over the past 5 years, Cartesian Therapeutics' Change in Receivables (Quarter) stood at $2.6 million in 2021, then tumbled by 112.7% to -$329000.0 in 2022, then surged by 395.44% to $972000.0 in 2023, then crashed by 507.1% to -$4.0 million in 2024, then soared by 109.3% to $368000.0 in 2025.
- Its Change in Receivables stands at $368000.0 for Q3 2025, versus -$1.4 million for Q2 2025 and $893000.0 for Q1 2025.